+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Functional Variants in Notch Pathway Genes NCOR2, NCSTN, and MAML2 Predict Survival of Patients with Cutaneous Melanoma



Functional Variants in Notch Pathway Genes NCOR2, NCSTN, and MAML2 Predict Survival of Patients with Cutaneous Melanoma



Cancer Epidemiology, Biomarkers and Prevention 24(7): 1101-1110



The Notch signaling pathway is constitutively activated in human cutaneous melanoma to promote growth and aggressive metastatic potential of primary melanoma cells. Therefore, genetic variants in Notch pathway genes may affect the prognosis of cutaneous melanoma patients. We identified 6,256 SNPs in 48 Notch genes in 858 cutaneous melanoma patients included in a previously published cutaneous melanoma genome-wide association study dataset. Multivariate and stepwise Cox proportional hazards regression and false-positive report probability corrections were performed to evaluate associations between putative functional SNPs and cutaneous melanoma disease-specific survival. Receiver operating characteristic curve was constructed, and area under the curve was used to assess the classification performance of the model. Four putative functional SNPs of Notch pathway genes had independent and joint predictive roles in survival of cutaneous melanoma patients. The most significant variant was NCOR2 rs2342924 T>C (adjusted HR, 2.71; 95% confidence interval, 1.73-4.23; Ptrend = 9.62 × 10(-7)), followed by NCSTN rs1124379 G>A, NCOR2 rs10846684 G>A, and MAML2 rs7953425 G>A (Ptrend = 0.005, 0.005, and 0.013, respectively). The receiver operating characteristic analysis revealed that area under the curve was significantly increased after adding the combined unfavorable genotype score to the model containing the known clinicopathologic factors. Our results suggest that SNPs in Notch pathway genes may be predictors of cutaneous melanoma disease-specific survival. Our discovery offers a translational potential for using genetic variants in Notch pathway genes as a genotype score of biomarkers for developing an improved prognostic assessment and personalized management of cutaneous melanoma patients.

(PDF emailed within 0-6 h: $19.90)

Accession: 057908408

Download citation: RISBibTeXText

PMID: 25953768

DOI: 10.1158/1055-9965.EPI-14-1380-T


Related references

Variants in Notch signalling pathway genes, PSEN1 and MAML2, predict overall survival in Chinese patients with epithelial ovarian cancer. Journal of Cellular and Molecular Medicine 22(10): 4975-4984, 2018

Genetic variants of PDGF signaling pathway genes predict cutaneous melanoma survival. Oncotarget 8(43): 74595-74606, 2017

Genetic variants in the integrin signaling pathway genes predict cutaneous melanoma survival. International Journal of Cancer 140(6): 1270-1279, 2016

Genetic variants of genes in the Notch signaling pathway predict overall survival of non-small cell lung cancer patients in the PLCO study. Oncotarget 7(38): 61716-61727, 2016

Genetic variants in the genes encoding rho GTPases and related regulators predict cutaneous melanoma-specific survival. International Journal of Cancer 141(4): 721-730, 2017

Genetic variants in the calcium signaling pathway genes are associated with cutaneous melanoma-specific survival. Carcinogenesis 2019, 2019

Genetic variants in the vitamin D pathway genes VDBP and RXRA modulate cutaneous melanoma disease-specific survival. Pigment Cell and Melanoma Research 29(2): 176-185, 2016

Potentially functional genetic variants in the TNF/TNFR signaling pathway genes predict survival of patients with non-small cell lung cancer in the PLCO cancer screening trial. Molecular Carcinogenesis 2019, 2019

Frequent fusion of the CRTC1 and MAML2 genes in clear cell variants of cutaneous hidradenomas. Genes, Chromosomes & Cancer 46(6): 559-563, 2007

Potentially functional variants in the core nucleotide excision repair genes predict survival in Japanese gastric cancer patients. Carcinogenesis 35(9): 2031-2038, 2014

Genetic variants in the metzincin metallopeptidase family genes predict melanoma survival. Molecular Carcinogenesis 57(1): 22-31, 2017

Regulatory variants in cancer-related pathway genes predict survival of patients with surgically resected non-small cell lung cancer. Gene 646: 56-63, 2018

Genetic variants in the PIWI-piRNA pathway gene DCP1A predict melanoma disease-specific survival. International Journal of Cancer 139(12): 2730-2737, 2016

Genetic variants in Hippo pathway genes YAP1, TEAD1 and TEAD4 are associated with melanoma-specific survival. International Journal of Cancer 137(3): 638-645, 2015

Genetic variants of cell cycle pathway genes predict disease-free survival of hepatocellular carcinoma. Cancer Medicine 6(7): 1512-1522, 2017